<DOC>
	<DOCNO>NCT01422161</DOCNO>
	<brief_summary>The purpose study determine whether injection botulinum toxin ( commonly know BOTOXÂ® ) affect hand Stroke patient , target muscle control hand , lead improve use hand compare injection placebo ( substance look similar study drug contains active study medication ) .</brief_summary>
	<brief_title>Study Botulinum Toxin Recovery Hand Function After Stroke</brief_title>
	<detailed_description>Hemiparesis common motor impairment stroke frequently lead persistent deficit hand function . This study investigate whether application botulinum toxin set synergistically-acting hand muscle , conjunction task-specific therapy , lead reorganization improve motor function stroke-involved hand . The investigator use objective psychophysical measure hand function hand function rating scale investigate Botox conjunction task-specific therapy lead : - improve motor execution , - improve motor plan psychophysical two-finger grasp lift task vary object weight , - increase hand function assess time take complete fine motor task .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Paresis</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>Ability follow study instruction likely complete require visit Ability comply therapy protocol assess investigator 3 month post firsttime unilateral stroke right leave hemiparesis complaint unilateral hand dysfunction Must ability grasp lift test object Subjects must upper extremity motor impairment Known allergy sensitivity botulinum toxin type A ( BOTOX ) . Females positive pregnancy test , breastfeeding , plan pregnancy study , think may pregnant start study female childbearing potential unable unwilling use reliable form contraception study . Concurrent participation another investigational drug device study participation another Botulinum toxin study 6 month prior study . Treatment botulinum toxin serotype 3 month prior study enrollment Any medical condition may put subject increase risk exposure BOTOX include diagnose myasthenia gravis , EatonLambert syndrome , amytrophic lateral sclerosis , disorder might interfere neuromuscular function . Evidence alcohol , drug abuse relevant neuropsychiatric condition . Infection skin disorder anticipate injection site . Any condition situation , investigator 's opinion , may put subject significant risk , confound study result , interfere significantly subject 's participation study . History surgery significant injury either upper extremity cause mechanical limitation preclude task performance . Previous neurological illness head trauma , prior stroke , epilepsy , demyelinate disease . Complicating medical problem uncontrolled hypertension , diabetes sign polyneuropathy , severe renal , cardiac pulmonary disease , evidence concurrent neurologic orthopedic condition preclude subject comply study protocol . Current treatment intrathecal baclofen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Rehabilitation</keyword>
	<keyword>Fingers</keyword>
	<keyword>Grasp</keyword>
	<keyword>Hand</keyword>
	<keyword>Strength</keyword>
	<keyword>Brain Infraction</keyword>
	<keyword>Pathology</keyword>
	<keyword>Physiopathology</keyword>
	<keyword>Functional Laterality</keyword>
	<keyword>Neuronal Plasticity</keyword>
	<keyword>Psychomotor Performance</keyword>
	<keyword>Biomechanics</keyword>
	<keyword>Touch</keyword>
	<keyword>Weight-Bearing</keyword>
</DOC>